Hamid, O.
1659  results:
Search for persons X
?
3

P2.04-03 EGRET: First-in-human Study of the Novel Antibody-..:

Aggarwal, C. ; Solomon, B. ; Spira, A....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S306 , 2023
 
?
4

868 Development & Implementation of a Patient Information L..:

Hamid, O ; Dorudi, Y ; Walker, T
British Journal of Surgery.  110 (2023)  Supplement_7 - p. , 2023
 
?
5

119O Long-term efficacy and patterns of response of lifileu..:

Medina, T. ; Chesney, J.A. ; Whitman, E....
Immuno-Oncology and Technology.  20 (2023)  - p. 100591 , 2023
 
?
7

35MO Number of IL-2 doses and clinical outcomes of tumor-in..:

Hassel, J.C. ; Sarnaik, A. ; Chesney, J....
Immuno-Oncology and Technology.  16 (2022)  - p. 100140 , 2022
 
?
8

150P Phase I study of fianlimab: A human lymphocyte activat..:

Hamid, O. ; Lewis, K. ; Weise, A....
Immuno-Oncology and Technology.  16 (2022)  - p. 100262 , 2022
 
?
9

196TiP A phase I study of REGN6569, a GITR monoclonal antib..:

Lakhani, N. ; Hamid, O. ; Braña, I....
Immuno-Oncology and Technology.  16 (2022)  - p. 100308 , 2022
 
?
10

127P Phase I study of fianlimab: A human lymphocyte activat..:

Cho, B.C. ; Dy, G. ; Kim, T.M....
Immuno-Oncology and Technology.  16 (2022)  - p. 100239 , 2022
 
?
12

A comparative study between the effect of radio-chemotherap..:

Elrashedy, M F ; Ahmed, S ; Hamid, O
QJM: An International Journal of Medicine.  113 (2020)  Supplement_1 - p. , 2020
 
?
 
?
14

Diagnostic reference level for computed tomography abdomina..:

Sulieman, A. ; Elnour, A. ; Mahmoud, M.Z....
Radiation Physics and Chemistry.  174 (2020)  - p. 108963 , 2020
 
?
15

Efficacité et tolérance de l'association du nivolumab (NIVO..:

Tawbi, H. ; Forsyth, P. ; Hodi, F.S....
Annales de Dermatologie et de Vénéréologie.  146 (2019)  12 - p. A333-A334 , 2019
 
1-15